Placebo Groupacupuncture group 1acupuncture group 2
Placebo Group: nonpenetrating placebo needles
acupuncture group 1: indwelling intradermal needles
acupuncture group 2: combining fire needle and regular acupuncture
Study summary
To conduct a multi-center, randomized, controlled clinical study aimed at formally evaluating the impact of different acupuncture methods on the success rate in patients with recurrent implantation failure
Eligibility
Sex
FEMALE
Min age
—
Max age
39 Years
Healthy volunteers
No
Inclusion Criteria:
1. Meets the criteria for RIF diagnosis (≥ 3 instances of unsuccessful transfer of high-quality embryos).
2. Age: \< 40 years.
3. Planning for a cycle involving the transfer of frozen-thawed embryos (FET).
4. Possession of a transplantable frozen blastocyst (≥3BB).
5. Endometrial thickness \>7 mm within the period of endometrial transformation.
Exclusion Criteria:
1. Individuals planning to undergo preimplantation genetic diagnosis (PGD).
2. Recipients of egg donations.
3. Chromosomal abnormalities in either spouse or one partner (excluding chromosomal polymorphisms).
4. Patients with known embryo-related factors leading to implantation failure.
5. Abnormalities of the uterus that may affect implantation (including uterine malformations, uterine tuberculosis, submucosal myomas, severe uterine adhesions, severe uterine endometriosis, myomas with a diameter of ≥4 cm, and so on).
6. Those with significant abnormalities in immunity or coagulation.
7. Individuals with other endocrine disorders, such as thyroid disorders, hyperprolactinemia, insulin resistance, diabetes, and adrenal disorders, whose hormone levels have not been well-controlled over the past 3 months.
8. Individuals with untreated hydrosalpinx;
9. Individuals with a Body Mass Index (BMI) below 18 and above 25 kg/ m2.
10. Men with severe abnormalities in semen quality.
11. Individuals with a history of needle phobia.
12. Individuals who have previously participated in this study or received acupuncture treatment within the past three months;
13. Any other conditions deemed unsuitable for participation by the researchers.
Primary outcome measure(s)
clinical pregnancy — 2 years defined as ultrasonographic detection of an intrauterine gestational sac following embryo transfer
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.